IP Library Granted Patent US 7,695,437
Granted Patent B2
US 7,695,437 · App. 11/027,912 · Granted Apr 13, 2010

Ultrasound therapy head with movement control

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,695,437
App. No.
11/027,912
Granted
Apr 13, 2010
Kind
B2
Abstract

A therapy head for use in HIFU procedures is described. The therapy head has an enclosure with a window, an energy applicator and a means of moving the energy applicator within the enclosure. The therapy head uses motors and actuators to move the energy applicator, usually an ultrasound transducer, inside the enclosure. A controller is provided either internally or externally that allows the therapy head to identify and distinguish locations where the therapy head should be to radiate energy into a patient. The controller uses the motors and actuators to move the energy applicator into the desired locations.

Claims (30)

1. A therapy head comprising:

an enclosure having a window, said enclosure adapted to be manipulated by hand;

at least one directional energy applicator suspended within said enclosure; and

a positioner programmed to maneuver the energy applicator within said enclosure, the positioner, comprising:

a first motor connected to a first traveler rod, the first traveler rod mechanically engaged to a first actuator;

a second motor connected to a second traveler rod, the second traveler rod mechanically engaged to a second actuator wherein the actuators are arranged to form an intersection between said first and second actuator, the directional energy applicator being movably positioned at the intersection of said first and second actuator;

wherein the positioner maneuvers the energy applicator to emit radiant energy through the window in order to deliver a precise energy dosage to patient tissue adjacent the window, and wherein the positioner is adapted to maneuver the energy application along a first axis controlled by said first motor and along a second axis controlled by said second motor, the second axis being perpendicular to the first axis.

2. The therapy head of claim 1 , wherein said window is a transmissible window for said energy applicator.

3. The therapy head of claim 1 , wherein said energy applicator is an ultrasound transducer.

4. The energy applicator of claim 3 , wherein said ultrasound transducer is a high intensity focused ultrasound transducer.

5. The therapy head of claim 1 , wherein the energy applicator is a component ultrasound transducer.

6. The therapy head of claim 1 , wherein the positioner for maneuvering said energy applicator includes one or more position sensors.

7. The therapy head of claim 1 , wherein said window is a disposable transducer seal.

8. The therapy head as described in claim 1 , wherein said positioner further comprising a plurality of encoders for measuring movement within said enclosure.

9. The therapy head of claim 1 , wherein said motors are electric motors.

10. The ultrasound head of claim 1 , wherein said positioner further comprises a plurality of encoders.

11. The therapy head of claim 1 , wherein said enclosure further comprises a horizontal water tight partition defining an upper enclosure and a lower enclosure, said upper enclosure containing said means for maneuvering and said lower enclosure containing said energy applicator, said window being in said lower enclosure.

12. The therapy head of claim 11 , further comprising a fluid circulation system for circulating a coupling fluid through said lower enclosure.

13. A system for directional application of energy over a body surface, the system comprising:

the therapy head of claim 1 ; and

a controller adapted for controlling movement of the energy applicator within the enclosure.

14. The system of claim 13 , wherein the controller is further adapted to control dosage delivered from the applicator to the tissue.

15. The system of claim 13 , wherein said controller includes a library of data used to coordinate movement and dosage.

16. A method of delivering ultrasound energy to a body surface, said method comprising:

engaging a hand held enclosure against a body surface;

positioning the enclosure manually over one location on the body surface; and

controlling a first motor and a second motor connected to a first actuator and a second actuator, respectively, to control the movement of an energy applicator according to a predetermined program within the hand held enclosure while the enclosure remains stationary relative to the body surface,

wherein controlling the first motor controls the movement of the energy applicator along a first axis and controlling the second actuator controls the movement of the energy applicator along a second axis perpendicular to the first axis.

17. The method of claim 16 , further comprising:

repositioning the enclosure manually to at least one additional location on the body surface and controlling the movement of the energy applicator within the hand held enclosure while the enclosure remains stationary relative to the body surface.

Assignments (17)
RELEASE OF SECURITY INTEREST Recorded Nov 20, 2025
From: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
To: BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH, CANADA INC.; BAUSCH HEALTH IRELAND LIMITED; SOLTA MEDICAL IRELAND LIMITED
Reel/Frame 073654/0300 →
RELEASE OF SECURITY INTEREST Recorded Nov 20, 2025
From: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
To: BAUSCH HEALTH AMERICAS, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.; MEDICIS PHARMACEUTICAL CORPORATION; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD.; SANTARUS, INC.; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.
Reel/Frame 073637/0126 →
U.S. PATENT SECURITY AGREEMENT Recorded Jun 13, 2025
From: MEDICIS PHARMACEUTICAL CORPORATION; ORAPHARMA, INC.; BAUSCH HEALTH US, LLC (F/K/A VALEANT PHARMACEUTICALS NORTH AMERICA LLC); PRECISION DERMATOLOGY, INC.; SALIX PHARMACEUTICALS, INC.; SANTARUS, INC.; BAUSCH HEALTH AMERICAS, INC.; SOLTA MEDICAL, INC.
To: THE BANK OF NEW YORK MELLON
Reel/Frame 071564/0463 →
U.S. PATENT SECURITY AGREEMENT Recorded Jun 13, 2025
From: MEDICIS PHARMACEUTICAL CORPORATION; ORAPHARMA, INC.; BAUSCH HEALTH US, LLC (F/K/A VALEANT PHARMACEUTICALS NORTH AMERICA LLC); PRECISION DERMATOLOGY, INC.; SALIX PHARMACEUTICALS, INC.; SANTARUS, INC.; BAUSCH HEALTH AMERICAS, INC.; SOLTA MEDICAL, INC.
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 071566/0200 →
SECURITY AGREEMENT (SECOND LIEN) Recorded Oct 5, 2022
From: BAUSCH HEALTH US, LLC; BAUSCH HEALTH AMERICAS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD.; SANTARUS, INC.; SOLTA MEDICAL, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 061606/0468 →
SECURITY AGREEMENT (FIRST LIEN) Recorded Oct 4, 2022
From: BAUSCH HEALTH US, LLC; BAUSCH HEALTH AMERICAS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD.; SANTARUS, INC.; SOLTA MEDICAL, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 061595/0066 →
SECURITY INTEREST Recorded Jun 13, 2022
From: BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH, CANADA INC.; BAUSCH HEALTH IRELAND LIMITED; SOLTA MEDICAL IRELAND LIMITED
To: THE BANK OF NEW YORK MELLON
Reel/Frame 060346/0705 →
MERGER Recorded May 17, 2021
From: LIPOSONIX, INC.
To: SOLTA MEDICAL, INC.
Reel/Frame 056257/0362 →
CHANGE OF NAME Recorded May 12, 2021
From: MEDICIS TECHNOLOGIES CORPORATION
To: LIPOSONIX, INC.
Reel/Frame 056228/0375 →
SECURITY INTEREST Recorded Mar 11, 2019
From: BAUSCH HEALTH AMERICAS, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.; MEDICIS PHARMACEUTICAL CORPORATION; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD.; SANTARUS, INC.; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 048556/0758 →
RELEASE OF SECURITY INTEREST IN PATENTS Recorded Jan 24, 2014
From: SILICON VALLEY BANK
To: LIPOSONIX, INC.
Reel/Frame 032126/0531 →
RELEASE OF SECURITY INTEREST IN PATENTS Recorded Jan 24, 2014
From: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.
To: LIPOSONIX, INC.
Reel/Frame 032126/0370 →
SHORT-FORM PATENT SECURITY AGREEMENT Recorded Nov 19, 2013
From: LIPOSONIX, INC.
To: CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P.; CAPITAL ROYALTY PARTNERS II L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.
Reel/Frame 031674/0454 →
SECURITY INTEREST - MEZZANINE LOAN Recorded Apr 18, 2013
From: LIPOSONIX, INC.
To: SILICON VALLEY BANK
Reel/Frame 030249/0268 →
SECURITY AGREEMENT Recorded Apr 3, 2013
From: LIPOSONIX, INC.
To: SILICON VALLEY BANK
Reel/Frame 030147/0642 →
CHANGE OF NAME Recorded Apr 24, 2009
From: LIPOSONIX, INC.
To: MEDICIS TECHNOLOGIES CORPORATION
Reel/Frame 022597/0363 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 13, 2005
From: QUISTGAARD, JENS U.; ETCHELLS, TIM; DARLINGTON, GREGORY PAUL; DESILETS, CHARLES S.
To: LIPOSONIX, INC.
Reel/Frame 016639/0438 →